| 1 | KIR2DL2, KIR2DS2
|
| Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.
|
| Salim PH, Jobim M, Bredemeier M, Chies JA, Schlottfeldt J, Brenol JC, Jobim LF, Xavier RM.
|
| Clin Exp Immunol lin Exp Immunol. 2010 Jan 15. [Epub ahead of print]PMID: 20082621 2010
|
| 2 | KIR2DS2
|
| Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.
|
| Middleton D, Diler AS, Meenagh A, Sleator C, Gourraud PA.
|
| Tissue Antigens 73(6):553-60.
2009
|
| 3 | KIR2DS2
|
| KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma.
|
| Pellett F, Siannis F, Vukin I, Lee P, Urowitz MB, Gladman DD.
|
| Tissue Antigens 69 Suppl 1:106-8.PMID: 17445179 2007
|
| 4 | KIR2DL1, KIR2DL2, KIR2DL3, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DS1
|
| Alternatively spliced forms of human killer inhibitory receptors.
|
| Dohring C, et al.
|
| Immunogenetics 44 : 227-230. 1996
|
| 5 | KIR2DL3, KIR2DS2, KIR2DS3, KIR3DL1, KIR3DL2
|
| Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains.
|
| Wagtmann N, et al.
|
| Immunity 2 : 439-449. 1995
|
| 6 | KIR2DL2, KIR2DL3, KIR2DL4, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5
|
| Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
|
| Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L.
|
| J Exp Med 182 : 875-884. 1995
|